Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu

Paul M. Barr, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Fax: (585) 273-5761

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting

Cancer

Biography

As the Director of the Clinical Trials Office for Wilmot Cancer Institute, I oversee our state-of-the-art clinical trials while also educating my patients about their disease so they are as informed as possible. This enables my patients to participate in the process of making the best treatment decisions.

Individual patients drew me into the field of hematology/oncology. I am driven by the desire to develop better, less toxic treatments for our lymphoma and leukemia patients. I also have an amazing team working with me that is focused on communicating with and educating our patients, helping them in every aspect of their lives.

If I were to recommend one thing to patients, it would be to ask about clinical trials. While a clinical trial may not be appropriate in every circumstance, all patients should learn about these important options.

Conditions I Treat

- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Chronic lymphocytic leukemia

Professional Background

Paul M. Barr, M.D. is an Associate Professor of Medicine and Director of the Clinical Trials Office for the Wilmot Cancer Institute.



Dr. Barr received his medical degree from Northeast Ohio Medical University. His postgraduate training included an internship, residency and chief residency at Case Western Reserve University. He subsequently completed a hematology and oncology fellowship at Case Western and now holds subspecialty certification in Internal Medicine, Hematology and Oncology.

He is a member of the lymphoma committee in the Southwest Oncology Group and serves as principal investigator on several local and national clinical trial treatment protocols for chronic lymphocytic leukemia and non-Hodgkin lymphoma.

His research interests focus on the development of novel therapeutics for patients with chronic lymphocytic leukemia and lymphoma. He has received a NIH funded K12 award during his training for his work with the organic amine Methoxyamine to improve the effect of fludarabine for CLL patients. Most recently, he was awarded a Clinical Research award from the Lymphoma Research Foundation based o his work developing combination therapies targeting molecules within the B cell receptor pathway for CLL and lymphoma patients.

Research

Paul M. Barr, M.D. is an Associate Professor of Medicine and Director of the Clinical Trials Office for the Wilmot Cancer Institute.

Dr. Barr received his medical degree from Northeast Ohio Medical University. His postgraduate training included an internship, residency and chief residency at Case Western Reserve University. He subsequently completed a hematology and oncology fellowship at Case Western and now holds subspecialty certification in Internal Medicine, Hematology and Oncology.

He is a member of the lymphoma committee in the Southwest Oncology Group and serves as principal investigator on several local and national clinical trial treatment protocols for chronic lymphocytic leukemia and non-Hodgkin lymphoma.

His research interests focus on the development of novel therapeutics for patients with chronic lymphocytic leukemia and lymphoma. He has received a NIH funded K12 award during his training for his work with the organic amine Methoxyamine to improve the effect of fludarabine for CLL patients. Most recently, he was awarded a Clinical Research award from the Lymphoma Research Foundation based o his work developing combination therapies targeting molecules within the B cell receptor pathway for CLL and lymphoma patients.

Credentials

Specialties

  • Hematology - American Board of Internal Medicine
  • Internal Medicine
  • Medical Oncology - American Board of Internal Medicine

Education

1996
BA | Miami University-Oxford
Zoology

2000
MD | Northeast Ohio Medical University
Medicine

Post-doctoral Training & Residency

07/01/2004 - 06/30/2007
Fellowship in Hematology/Oncology at University Hospitals of Cleveland

07/01/2001 - 06/30/2003
Residency in Internal Medicine at University Hospitals of Cleveland

07/01/2000 - 06/30/2001
Internship in Internal Medicine at University Hospitals of Cleveland

VIEW ALL expand_more

Awards

2012 - 2015
Lymphoma Research Foundation Clinical Investigator

2011 - 2014
NIH Loan Repayment Program Award Recipient
Sponsor: NIH

2011 - 2014
Wilmot Cancer Research Fellowship

2009
American Society of Hematology Clinical Research Training Institute

2008
NIH/NCI K12 Paul Calabresi Scholar
Sponsor: NIH
Location: University Hospitals Case Medical Center, Case Western Reserve

2006 - 2007
John W. Harris, MD Hematology Scholar Award
Location: Case Western Reserve University

2003 - 2004
Chief Medical Resident
Location: Case Western Reserve University/University Hospitals

1996
Department of Zoology Honors Program

1996
Phi Beta Kappa

1995
Howard Hughes Summer Scholars Program

1995
Miami MED Premedical Honorary

VIEW ALL expand_more

Publications

Journal Articles

3/9/2020
Williams AM, van Wijngaarden E, Seplaki CL, Heckler CE, Weber MT, Barr PM, Zent CS, Janelsins MC. "Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment." Leukemia & lymphoma.. 2020 Mar 9; :1-9. Epub 2020 Mar 09.

2/20/2020
Eyre TA, Lamanna N, Roeker LE, Ujjani CS, Hill BT, Barr PM, Lansigan E, Cheson BD, Yazdy M, Allan JN, Rhodes J, Schuster SJ, Nabhan C, Skarbnik A, Leslie L, Islam P, Whitaker K, Coombs CC, Tuncer HH, Pagel JM, Jacobs R, Winter AM, Bailey N, Sitlinger A, Schuh AH, Follows G, Fox CP, Brander DM, Shadman M, Mato AR. "Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia." Haematologica.. 2020 Feb 20; Epub 2020 Feb 20.

1/17/2020
Moore J, Baran AM, Meacham PJ, Evans AG, Barr PM, Zent CS. "Initial treatment of B-cell prolymphocytic leukemia with ibrutinib." American journal of hematology.. 2020 Jan 17; Epub 2020 Jan 17.

Books & Chapters

2019
Book Title: How I treat early relapsing follicular lymphoma
Author List: Casulo C, Barr PM
Published By: Blood 2019

2019
Book Title: Augmenting Indolent Lymphoma Treatment Options with the Combination of Lenalidomide and Rituximab.
Author List: Barr PM
Published By: J Clin Oncology 2019

2018
Book Title: COUNTERPOINT: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
Author List: Barr PM
Published By: Oncology 2018

VIEW ALL PUBLICATIONS